Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Pan-cancer characterization of long non-coding RNA and DNA methylation mediated transcriptional dysregulation
Zhen Yang1, Feng Xu2, Haizhou Wang2
1Center for Medical Research and Innovation of Pudong Hospital, Fudan University, and the Shanghai Key Laboratory of Medical Epigenetics, the International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Background:
Disruption of DNA methylation (DNAm) is one of the key signatures of cancer, however, detailed mechanisms that alter the DNA methylome in cancer remain to be elucidated.
Methods:
Here we present a novel integrative analysis framework, called MeLncTRN (Methylation mediated LncRNA Transcriptional Regulatory Network), that integrates genome-wide transcriptome, DNA methylome and copy number variation profiles, to systematically identify the epigenetically-driven lncRNA-gene regulation circuits across 18 cancer types.
Finding:
We show that a significant fraction of the aberrant DNAm and gene expression landscape in cancer is associated with long noncoding RNAs (lncRNAs). We reveal distinct types of regulation between lncRNA modulators and target genes that are operative in either only specific cancers or across cancers. Functional studies identified a common theme of cancer hallmarks that lncRNA modulators may participate in. The coupled lncRNA gene interactions via DNAm also serve as markers for classifications of cancer subtypes with different prognoses.
Interpretation:
Our study reveals a vital layer of DNAm and associated expression regulation for many cancer-related genes and we also provide a valuable database resource for interrogating epigenetically mediated lncRNA-gene interactions in cancer.
Funding:
National Natural Science Foundation of China [91959106, 31871255].
Insights
Cancer epigenetics involves DNA methylation (DNAm) disruptions. This study identifies long noncoding RNA (lncRNA) gene regulatory networks driven by DNAm, revealing new cancer subtype markers and therapeutic targets.
Area of Science:
- Genomics
- Epigenetics
- Cancer Biology
Background:
- DNA methylation (DNAm) disruption is a hallmark of cancer.
- Mechanisms altering the cancer methylome require further elucidation.
Purpose of the Study:
- To systematically identify epigenetically-driven lncRNA-gene regulatory circuits in cancer.
- To develop an integrative analysis framework for cancer epigenetics research.
Main Methods:
- Developed MeLncTRN (Methylation mediated LncRNA Transcriptional Regulatory Network) framework.
- Integrated genome-wide transcriptome, DNA methylome, and copy number variation data.
- Analyzed 18 cancer types to identify lncRNA-gene regulation.
Main Results:
- A significant portion of aberrant DNAm and gene expression in cancer is linked to long noncoding RNAs (lncRNAs).
- Identified distinct lncRNA-gene regulatory patterns specific to or across cancer types.
- lncRNA modulators are implicated in cancer hallmarks and serve as prognostic markers for cancer subtypes.
Conclusions:
- Revealed a critical layer of DNAm-associated gene regulation involving lncRNAs in cancer.
- Provided a valuable database for exploring epigenetically mediated lncRNA-gene interactions in cancer.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
06:57Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
Published on: July 7, 2023
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Non-LTR Retrotransposons
MicroRNAs